New Jersey Clinical Trial Operations Exam
Question and correct answers (verified
answers 100%) Q&A 2026/2027 INSTANT
DOWNLOAD PDF
1. What is the primary purpose of Good Clinical Practice (GCP) guidelines in
clinical trials?
A. To increase product sales
B. To ensure ethical and scientific quality standards
C. To reduce manufacturing costs
D. To advertise investigational products
Rationale: GCP guidelines protect trial participants and ensure the credibility and
accuracy of clinical trial data.
2. Who is ultimately responsible for the conduct of a clinical trial at a study site?
A. Clinical Research Associate
B. Sponsor
C. Principal Investigator
D. Pharmacist
Rationale: The Principal Investigator (PI) is accountable for all aspects of trial
conduct at the site.
3. What document outlines the objectives, design, methodology, and
organization of a clinical trial?
,A. Case Report Form
B. Investigator Brochure
C. Clinical Trial Protocol
D. Source Document
Rationale: The protocol serves as the blueprint for conducting the study.
4. Before participating in a clinical trial, subjects must provide:
A. Insurance information
B. Medical history only
C. Informed Consent
D. Employment records
Rationale: Informed consent ensures participants understand the risks, benefits,
and procedures involved.
5. What is the role of an Institutional Review Board (IRB)?
A. Manufacture study drugs
B. Review and approve research involving human subjects
C. Monitor product sales
D. Conduct laboratory testing
Rationale: IRBs safeguard the rights, safety, and welfare of research participants.
6. Which phase of a clinical trial primarily evaluates safety in humans?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Rationale: Phase I studies focus on safety, dosage, and side effects.
,7. Which document provides investigators with information about an
investigational product?
A. Laboratory Report
B. Investigator Brochure
C. Financial Statement
D. Monitoring Plan
Rationale: The Investigator Brochure contains clinical and nonclinical information
relevant to the study drug.
8. What is a Case Report Form (CRF)?
A. Participant diary only
B. Regulatory submission document
C. Tool for recording protocol-required data
D. Marketing report
Rationale: CRFs collect and document study data for each participant.
9. A sponsor is responsible for:
A. Managing participant appointments only
B. Initiating and overseeing a clinical trial
C. Approving hospital budgets
D. Performing all laboratory analyses
Rationale: Sponsors are responsible for trial management, financing, and
oversight.
10. What is source documentation?
, A. Copies of advertisements
B. Original records where trial data are first recorded
C. Accounting records
D. Drug labels only
Rationale: Source documents provide evidence supporting trial data and
participant care.
11. Which term refers to any unfavorable medical occurrence during a clinical
trial?
A. Protocol deviation
B. Adverse Event (AE)
C. Monitoring visit
D. Audit finding
Rationale: An adverse event is any undesirable experience associated with study
participation.
12. A Serious Adverse Event (SAE) includes:
A. Mild headache only
B. Temporary fatigue
C. Event resulting in hospitalization or death
D. Missed appointment
Rationale: SAEs involve significant medical outcomes such as hospitalization,
disability, or death.
13. What is randomization in clinical research?
A. Assigning participants by age
B. Assigning participants by physician choice
Question and correct answers (verified
answers 100%) Q&A 2026/2027 INSTANT
DOWNLOAD PDF
1. What is the primary purpose of Good Clinical Practice (GCP) guidelines in
clinical trials?
A. To increase product sales
B. To ensure ethical and scientific quality standards
C. To reduce manufacturing costs
D. To advertise investigational products
Rationale: GCP guidelines protect trial participants and ensure the credibility and
accuracy of clinical trial data.
2. Who is ultimately responsible for the conduct of a clinical trial at a study site?
A. Clinical Research Associate
B. Sponsor
C. Principal Investigator
D. Pharmacist
Rationale: The Principal Investigator (PI) is accountable for all aspects of trial
conduct at the site.
3. What document outlines the objectives, design, methodology, and
organization of a clinical trial?
,A. Case Report Form
B. Investigator Brochure
C. Clinical Trial Protocol
D. Source Document
Rationale: The protocol serves as the blueprint for conducting the study.
4. Before participating in a clinical trial, subjects must provide:
A. Insurance information
B. Medical history only
C. Informed Consent
D. Employment records
Rationale: Informed consent ensures participants understand the risks, benefits,
and procedures involved.
5. What is the role of an Institutional Review Board (IRB)?
A. Manufacture study drugs
B. Review and approve research involving human subjects
C. Monitor product sales
D. Conduct laboratory testing
Rationale: IRBs safeguard the rights, safety, and welfare of research participants.
6. Which phase of a clinical trial primarily evaluates safety in humans?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Rationale: Phase I studies focus on safety, dosage, and side effects.
,7. Which document provides investigators with information about an
investigational product?
A. Laboratory Report
B. Investigator Brochure
C. Financial Statement
D. Monitoring Plan
Rationale: The Investigator Brochure contains clinical and nonclinical information
relevant to the study drug.
8. What is a Case Report Form (CRF)?
A. Participant diary only
B. Regulatory submission document
C. Tool for recording protocol-required data
D. Marketing report
Rationale: CRFs collect and document study data for each participant.
9. A sponsor is responsible for:
A. Managing participant appointments only
B. Initiating and overseeing a clinical trial
C. Approving hospital budgets
D. Performing all laboratory analyses
Rationale: Sponsors are responsible for trial management, financing, and
oversight.
10. What is source documentation?
, A. Copies of advertisements
B. Original records where trial data are first recorded
C. Accounting records
D. Drug labels only
Rationale: Source documents provide evidence supporting trial data and
participant care.
11. Which term refers to any unfavorable medical occurrence during a clinical
trial?
A. Protocol deviation
B. Adverse Event (AE)
C. Monitoring visit
D. Audit finding
Rationale: An adverse event is any undesirable experience associated with study
participation.
12. A Serious Adverse Event (SAE) includes:
A. Mild headache only
B. Temporary fatigue
C. Event resulting in hospitalization or death
D. Missed appointment
Rationale: SAEs involve significant medical outcomes such as hospitalization,
disability, or death.
13. What is randomization in clinical research?
A. Assigning participants by age
B. Assigning participants by physician choice
